Wei Li Lin
Director/Board Member at HANDA PHARMACEUTICALS, INC.
Profile
Wei Li Lin is currently the Chairman of Chuan Fa Biotechnology Co. Ltd., Director-Supervisory Board of Microbio (Shanghai) Co., Ltd., and an Independent Director at Handa Pharmaceuticals, Inc. He previously served as Chairman, President & Spokesman at Fountain Biopharma, Inc. and as a Director at OBI Pharma, Inc. Dr. Lin holds a doctorate degree from Kansas State University.
Wei Li Lin active positions
| Companies | Position | Start |
|---|---|---|
| HANDA PHARMACEUTICALS, INC. | Director/Board Member | 2017-09-27 |
| Microbio (Shanghai) Co., Ltd. | Director/Board Member | - |
| Chuan Fa Biotechnology Co. Ltd. | Chairman | - |
Former positions of Wei Li Lin
| Companies | Position | End |
|---|---|---|
| OBI PHARMA, INC. | Director/Board Member | 2012-12-19 |
| FOUNTAIN BIOPHARMA INC | Chairman | - |
Training of Wei Li Lin
| Kansas State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OBI PHARMA, INC. | Health Technology |
| HANDA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Microbio (Shanghai) Co., Ltd. | |
Fountain Biopharma, Inc.
 Fountain Biopharma, Inc. Pharmaceuticals: OtherHealth Technology Fountain Biopharma, Inc. engages in the research, development and sales of antibody drugs. Its products include anti-allergic monoclonal antibody drugs, monoclonal antibody drugs, immune checkpoint aptamer drugs, anti-lag-3 immunological checkpoint aptamer drugs and anti-tumor stem cell labeled antibody drugs. The company was founded on November 25, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
| Chuan Fa Biotechnology Co. Ltd. |
- Stock Market
- Insiders
- Wei Li Lin